The treatment of Stage IV carcinoma of cervix by radical dose radiotherapy
- 1. Glasgow Inst. of Radiotherapeutics and Oncology (UK)
- 2. Belgian Cancer Foundation, Brussels (Belgium)
- 3. West of Scotland Cancer Surveillance Unit, Ruchill Hospital, Glasgow (UK)
Description
During 1974-1979, 92 patients (14% of all carcinoma cervix cases) were assigned to Stage IV; 68 (10%) to Stage IVa and 24 (4%) to Stage IVb. Fifty-five patients were treated radically using 4 MeV X-rays (42.5 Gy in 20 fractions) followed by a 137Cs insertion (33.5 Gy to the A points). Twenty-six patients were treated palliatively and 11 received no treatment. Sixteen percent of radically treated patients were alive at 5 years, whereas all patients treated palliatively were dead in 18 months. Pelvic tumour was eliminated in 22/55 (40%) treated radically, but in only 1/26 treated palliatively. The 5-year survival for Stage IVa treated radically was 18% and 19/44 (43%) had local tumour control. Only one patient in Stage IVb (involvement of vulva) was alive at 5 years. The overall 5-year survival for Stage IV patients in this series was 11/92 (12%). 12 refs.; 2 figs.; 3 tabs
Additional details
Publishing Information
- Journal Title
- Radiotherapy and Oncology
- Journal Volume
- 11
- Journal Issue
- 1
- Series
- Radiother. Oncol.
- Journal Page Range
- 15-19
- ISSN
- 0167-8140
- CODEN
- RAOND
INIS
- Country of Publication
- Ireland
- Country of Input or Organization
- Netherlands
- INIS RN
- 20026770
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- CARCINOMAS; CESIUM 137; FRACTIONATED IRRADIATION; METASTASES; MEV RANGE 01-10; RADIATION SOURCE IMPLANTS; RADIOTHERAPY; SURVIVAL CURVES; UROGENITAL SYSTEM DISEASES; UTERUS
- Descriptors DEC
- BETA DECAY RADIOISOTOPES; BETA-MINUS DECAY RADIOISOTOPES; BODY; CESIUM ISOTOPES; DISEASES; ENERGY RANGE; FEMALE GENITALS; IMPLANTS; INTERMEDIATE MASS NUCLEI; IRRADIATION; ISOTOPES; MEDICINE; MEV RANGE; NEOPLASMS; NUCLEI; ODD-EVEN NUCLEI; ORGANS; RADIATION SOURCES; RADIOISOTOPES; THERAPY; YEARS LIVING RADIOISOTOPES